From Our 2010 Archives
Rising Drug Prices Slam Some Medicare Recipients
Latest Senior Health News
FRIDAY, March 19 (HealthDay News) -- Medicare Part D Plan coverage gap prices for widely used brand name drugs rose in 2010, and price increases since 2006 have far exceeded the rate of inflation, a new study finds.
Kaiser Family Foundation researchers checked the Medicare Web site for prices of commonly used brand-name drugs without a generic substitute for enrollees in stand-alone prescription drug plans. The prices are how much enrollees would pay for a 30-day supply of a drug after they reach the coverage gap (which begins after total drug spending reaches $3,610) and before they qualify for catastrophic coverage.
Among the findings:
People enrolled in Part D plans who reach the coverage gap have significant out-of-pocket expenses before they qualify for catastrophic coverage, the researchers said in a Kaiser news release. For example, an elderly women taking Actonel, Aricept and Plavix would spend $448 per month in 2010 after she reached the coverage gap, which would take about six months. She would remain in the coverage gap for the rest of the year.
-- Robert Preidt
Copyright © 2010 HealthDay. All rights reserved.
SOURCE: Kaiser Family Foundation, news release, March 16, 2010
- Allergic Skin Disorders
- Bacterial Skin Diseases
- Bites and Infestations
- Diseases of Pigment
- Fungal Skin Diseases
- Medical Anatomy and Illustrations
- Noncancerous, Precancerous & Cancerous Tumors
- Oral Health Conditions
- Papules, Scales, Plaques and Eruptions
- Scalp, Hair and Nails
- Sexually Transmitted Diseases (STDs)
- Vascular, Lymphatic and Systemic Conditions
- Viral Skin Diseases
- Additional Skin Conditions